Effects of empagliflozin on the urinary albumin-to-creatinine ratio in patients with type 2 diabetes and established cardiovascular disease: an exploratory analysis from the EMPA-REG OUTCOME randomised, placebo-controlled trial
Cao S, Pan Y, Tang J, Terker AS, Arroyo Ornelas JP, Jin G-N, Wang Y, Niu A, Fan X, Wang S
About half expect a supportive response from family and friends, and 94% feel confident their relatives will respect their food choices
Struggling with Your Self-Image
Secretin exerts its effects by binding to a specific receptor, the secretin receptor (SR) which is a GPCR of the class B secretin-like family of receptors
The FDA has approved three GLP-1s in particular for both type 2 diabetes treatment and weight loss: Liraglutide (Saxenda, Victoza): While effective, this once-daily injection generally leads to more modest weight loss compared to newer options (its been around since 2014)